Vibe By California Unveils New Hype Extracts Products for Consumers
2019年8月8日 - 9:12PM
Vibe Bioscience Ltd. (CSE: VIBE) (the “Company” or “Vibe”), a
vertically integrated cannabis retailer and cultivator, today
unveiled the launch of the Company’s new Hype Extracts product
line, including distillate vape cartridges and wax concentrates.
The arrival of Hype Extracts marks the debut of Vibe’s presence in
the concentrates market.
“This new product launch with Hype Extracts complements Vibe’s
Hype Cannabis Co. flower, providing our customers with a new
experience with concentrates,” said Mark Waldron, CEO, Vibe.
“Leveraging our Vibe by California™ brand and further supporting
the local market, we are working with two Sacramento-area
manufacturers to produce Hype Extracts and will continue to
collaborate with them for the development of future products.”
Hype Extracts products are made with Vibe’s own pesticide-free
cultivated materials in Sacramento, grown in-house and supplied to
two local manufacturers. Vibe plans to provide additional products
for its customers in the near future, including live resin vape
cartridges and other concentrated products.
The Hype Extracts products will be added to Vibe’s inventory in
August and available at all Vibe by California locations.
About Vibe Bioscience Ltd. Vibe is a vertically
integrated cannabis company delivering exceptional retail
experiences with its Vibe by California brand and ethos, premier
cultivation product and high-efficiency delivery and distribution.
The Company’s management team brings expertise in retail, cannabis
cultivation and mergers and acquisitions to support its U.S.
expansion through accretive acquisitions and organic growth.
For more information, please visit www.vibebycalifornia.com.
Forward-Looking Information Certain statements
contained in this press release constitute forward-looking
information. These statements relate to future events or future
performance. The use of any of the words “anticipate”, “could”,
“intend”, “expect”, “believe”, “will”, “projected”, “estimated” and
similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking
information and are based on the parties’ current belief or
assumptions as to the outcome and timing of such future events.
Actual future results may differ materially.
The forward-looking information contained in this release is
made as of the date hereof and the parties are not obligated to
update or revise any forward-looking information, whether as a
result of new information, future events or otherwise, except as
required by applicable securities laws. Because of the risks,
uncertainties and assumptions contained herein, investors should
not place undue reliance on forward looking information. The
foregoing statements expressly qualify any forward-looking
information contained herein. Risk factors related to the Company
are described in the Company’s Listing Statement dated March 25,
2019, a copy of which is available under the Company’s profile on
SEDAR.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities in the United
States. The securities have not been and will not be registered
under the United States Securities Act of 1933, as amended (the
“U.S. Securities Act”) or any State securities laws and may not be
offered or sold within the United States or to U.S. Persons unless
registered under the U.S. Securities Act and applicable State
securities laws or an exemption from such registration is
available. Not for distribution to U.S. Newswire Services or for
dissemination in the United States. Any failure to comply with this
restriction may constitute a violation of U.S. securities laws.
Unlike in Canada which has Federal legislation uniformly
governing the cultivation, distribution, sale and possession of
medical cannabis under the Cannabis Act (Federal), readers are
cautioned that in the U.S., cannabis is largely regulated at the
State level. To the knowledge of Vibe Bioscience Ltd., there are to
date a total of 33 states, plus the District of Columbia, that have
legalized cannabis in some form. Notwithstanding the permissive
regulatory environment of medical cannabis at the State level,
cannabis continues to be categorized as a controlled substance
under the Controlled Substances Act in the U.S. and as such,
cannabis-related practices or activities, including without
limitation, the manufacture, importation, possession, use or
distribution of cannabis are illegal under U.S. Federal law. Strict
compliance with State laws with respect to cannabis will neither
absolve Vibe Bioscience Ltd. of liability under the U.S. Federal
law, nor will it provide a defense to any Federal proceeding, which
may be brought against Vibe Bioscience Ltd. Any such proceedings
brought against Vibe Bioscience Ltd. may adversely affect its
operations and financial performance.
Company Contacts:Ryan Mercier, Chief Financial
OfficerPhone: 833.420.VIBE x102Email:
ryanm@vibebycalifornia.com Website:www.vibebycalifornia.com
Tyler R. Townsend, VP, FinancePhone: 833.420.VIBE x107Email:
tylert@vibebycalifornia.com
Website:www.vibebycalifornia.com
Investor Contact:Allison Soss, Vice
PresidentKCSA Strategic CommunicationsPhone: 212.896.1267Email:
Vibe@KCSA.com
Media Contacts:Caitlin Kasunich / Dave
Schemelia KCSA Strategic Communications Phone: 212.896.1241 /
212.896.1242Email: Vibe@KCSA.com
Vibe Growth (CSE:VIBE)
過去 株価チャート
から 11 2024 まで 12 2024
Vibe Growth (CSE:VIBE)
過去 株価チャート
から 12 2023 まで 12 2024